-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Biodesix, Lowers Price Target to $30

Benzinga·11/07/2026 01:30:53
Listen to the news
Lake Street analyst Thomas Flaten maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $40 to $30.